Mark Webster

9.5k total citations · 3 hit papers
213 papers, 6.7k citations indexed

About

Mark Webster is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mark Webster has authored 213 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 140 papers in Cardiology and Cardiovascular Medicine, 120 papers in Surgery and 65 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mark Webster's work include Coronary Interventions and Diagnostics (93 papers), Cardiac Imaging and Diagnostics (62 papers) and Cardiac Valve Diseases and Treatments (44 papers). Mark Webster is often cited by papers focused on Coronary Interventions and Diagnostics (93 papers), Cardiac Imaging and Diagnostics (62 papers) and Cardiac Valve Diseases and Treatments (44 papers). Mark Webster collaborates with scholars based in New Zealand, United States and Australia. Mark Webster's co-authors include John A. Ormiston, Patrick W. Serruys, Peter Ruygrok, Leif Thuesen, Dariusz Dudek, Bruce Webber, Yoshinobu Onuma, D. N. Sharpe, Héctor M. García‐García and Susan Veldhof and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Mark Webster

203 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PATENT FORAMEN OVALE IN YOUNG STROKE PATIENTS

1988 633 citations Mark Webster et al. profile →
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods

2009 584 citations Patrick W. Serruys, John A. Ormiston et al. profile →
A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

2008 496 citations John A. Ormiston, Patrick W. Serruys et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Webster New Zealand	39	4.0k	3.9k	2.4k	1.5k	422	213	6.7k
Campbell Rogers United States	43	4.4k 1.1×	2.8k 0.7×	1.8k 0.7×	1.5k 1.0×	350 0.8×	114	6.6k
Bruno Scheller Germany	42	6.0k 1.5×	3.5k 0.9×	2.9k 1.2×	2.3k 1.6×	350 0.8×	183	7.6k
Juan F. Granada United States	39	3.2k 0.8×	2.9k 0.7×	1.6k 0.7×	1.1k 0.8×	603 1.4×	206	5.7k
Giora Weisz United States	51	5.8k 1.4×	5.1k 1.3×	1.9k 0.8×	3.3k 2.3×	467 1.1×	242	8.8k
Carlo Briguori Italy	46	4.3k 1.1×	3.9k 1.0×	1.8k 0.7×	1.9k 1.3×	266 0.6×	220	7.6k
Franz R. Eberli Switzerland	48	5.1k 1.3×	5.2k 1.3×	2.0k 0.8×	2.2k 1.5×	602 1.4×	178	9.5k
Annapoorna Kini United States	44	5.2k 1.3×	4.7k 1.2×	2.0k 0.8×	2.4k 1.7×	724 1.7×	428	7.4k
Elena Ladich United States	41	6.4k 1.6×	5.0k 1.3×	3.0k 1.2×	1.9k 1.3×	823 2.0×	100	8.9k
Albert E. Raizner United States	42	3.8k 0.9×	4.1k 1.0×	2.1k 0.9×	2.6k 1.8×	562 1.3×	160	7.0k
Fumiyuki Otsuka Japan	35	4.2k 1.0×	3.3k 0.9×	1.9k 0.8×	1.7k 1.2×	970 2.3×	125	7.9k

Countries citing papers authored by Mark Webster

Since Specialization

Citations

This map shows the geographic impact of Mark Webster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Webster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Webster more than expected).

Fields of papers citing papers by Mark Webster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Webster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Webster. The network helps show where Mark Webster may publish in the future.

Co-authorship network of co-authors of Mark Webster

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Webster. A scholar is included among the top collaborators of Mark Webster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Webster. Mark Webster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gharleghi, Ramtin, Mingzi Zhang, Lucy McGrath‐Cadell, et al.. (2025). Sex-Specific Variances in Anatomy and Blood Flow of the Left Main Coronary Bifurcation: Implications for Coronary Artery Disease Risk. IEEE Transactions on Biomedical Engineering. 72(7). 2130–2137. 1 indexed citations

Gharleghi, Ramtin, Lucy McGrath‐Cadell, Robert M. Graham, et al.. (2022). Accuracy of vascular tortuosity measures using computational modelling. Scientific Reports. 12(1). 865–865. 31 indexed citations

Webster, Mark, Keith Ameiss, Paul J. Dominowski, et al.. (2022). Experimental veterinary SARS-CoV-2 vaccine cross neutralization of the Delta (B.1.617.2) variant virus in cats. Veterinary Microbiology. 268. 109395–109395. 6 indexed citations

Stewart, James T., James Blake, David Smyth, et al.. (2022). CLINICAL PREDICTORS OF EMBOLIC BURDEN AFTER TAVR: AN ANALYSIS OF THE SAFEPASS 2 CLINICAL STUDY. Journal of the American College of Cardiology. 79(9). 628–628. 1 indexed citations

Wang, Tom Kai Ming, Peter Ruygrok, Karishma Sidhu, et al.. (2019). Characteristics and Outcomes of Patients With Severe Aortic Stenosis Discussed by the Multidisciplinary “Heart Team” According to Treatment Allocation. Heart Lung and Circulation. 29(3). 368–373. 7 indexed citations

Chatfield, Andrew, et al.. (2019). Valve-in-Valve in a Flail Bioprosthetic Mitral Valve With Endocarditis Using a Novel Embolic Protection Device. SHILAP Revista de lepidopterología. 1(5). 787–791.

Lee, Mildred, et al.. (2018). Seasonal variation in Takotsubo syndrome compared with myocardial infarction: ANZACS-QI 16.. PubMed. 131(1471). 21–29. 9 indexed citations

Pilmore, Helen, et al.. (2017). Management of coronary artery disease in patients on dialysis.. PubMed. 130(1467). 11–22. 5 indexed citations

Ormiston, John A., et al.. (2017). Coronary balloon catheter tip damage. A bench study of a clinical problem. Catheterization and Cardiovascular Interventions. 92(5). 883–889. 2 indexed citations

10.

Watson, Timothy, et al.. (2014). Coronary spasm provocation testing: still useful?. Cardiovascular Medicine. 17(2). 46–47. 1 indexed citations

11.

Ormiston, John A., Mark Webster, James T. Stewart, et al.. (2013). First-in-Human Evaluation of a Bioabsorbable Polymer–Coated Sirolimus-Eluting Stent. JACC: Cardiovascular Interventions. 6(10). 1026–1034. 24 indexed citations

12.

Verheye, Stefan, Mark Webster, Jim Stewart, et al.. (2013). CRT-4 Multi-center, First-in-man Evaluation Of The Myolimus-eluting Bioresorbable Coronary Scaffold: 6-month Clinical And Imaging Results. JACC: Cardiovascular Interventions. 6(2). S2–S2. 1 indexed citations

13.

Ormiston, John A., Susann Beier, Brett R. Cowan, & Mark Webster. (2012). Reply. JACC: Cardiovascular Interventions. 5(3). 362–363. 1 indexed citations

14.

Ormiston, John A., Bruce Webber, & Mark Webster. (2011). Stent Longitudinal Integrity. JACC: Cardiovascular Interventions. 4(12). 1310–1317. 138 indexed citations

15.

Bruining, Nico, Sebastiaan de Winter, Jos R.T.C. Roelandt, et al.. (2010). Monitoring In Vivo Absorption of a Drug-Eluting Bioabsorbable Stent With Intravascular Ultrasound-Derived Parameters. JACC: Cardiovascular Interventions. 3(4). 449–456. 30 indexed citations

16.

Ormiston, John A., Mark Webster, Robert S. Schwartz, et al.. (2009). Feasibility, Safety, and Efficacy of a Novel Polymeric Pimecrolimus-Eluting Stent. JACC: Cardiovascular Interventions. 2(10). 1017–1024. 4 indexed citations

17.

O’Neill, Maggie, Philip A. Woods, & Mark Webster. (2005). New Arrivals: Participatory Action Research, Imagined Communities, and "Visions" of Social Justice. Social Justice A Journal of Crime Conflict & World Order. 32(1). 75. 6 indexed citations

18.

Holmes, David R., Robert S. Schwartz, & Mark Webster. (1991). Coronary restenosis: What have we learned from angiography?. Journal of the American College of Cardiology. 17(6). 14–22. 36 indexed citations

19.

Heras, Magda, James H. Chesebro, Mark Webster, et al.. (1990). Antithrombotic efficacy of low molecular weight heparin after arterial injury in the pig. Journal of the American College of Cardiology. 15(2). A188–A188. 3 indexed citations

20.

Heras, M., et al.. (1989). Hirudin Shows Critical Role of Thrombin in Arterial Thrombosis. Thrombosis and Haemostasis. 62(1). 187–187. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact